Effectiveness of ceftazidime/avibactam as a continuous infusion in critically ill patients with OXA-48-producing Klebsiella pneumoniae infection
Introduction. Ceftazidime/avibactam, a novel beta-lactam antibiotic, demonstrates time-dependent bacterial killing; thus, new reports advocate its administration as a continuous infusion, as opposed to bolus or prolonged infusion application. Methods. Critically ill COVID-19 patients (n=10) superinf...
Saved in:
| Main Authors: | Ivan Šitum, Dora Karmelić, Anja Mandarić, Ante Erceg, Daniel Lovrić, Marko Siroglavić, Slobodan Mihaljević, Mirabel Mažar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2024-06-01
|
| Series: | Romanian Medical Journal |
| Subjects: | |
| Online Access: | https://rmj.com.ro/articles/2024.2/RMJ_2024_2_Art-15.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an OXA-48 endemic area
by: Şevval Arduç Tok, et al.
Published: (2024-12-01) -
CPAP vs HFNC in treatment of patients with COVID-19 ARDS: A retrospective propensity-matched study
by: Ivan Šitum, et al.
Published: (2024-10-01) -
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study
by: Yu CH, et al.
Published: (2024-12-01) -
Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
by: Yitan Li, et al.
Published: (2024-12-01) -
A Novel Variant of KPC-179 Conferring Ceftazidime-Avibactam Resistance in a Carbapenem-Resistant Klebsiella pneumoniae Isolate
by: Liao Q, et al.
Published: (2024-11-01)